Caris Life Sciences, Inc. (CAI)
16.96
+0.82
(+5.08%)
USD |
NASDAQ |
Jun 09, 16:00
16.96
0.00 (0.00%)
After-Hours: 20:00
Caris Life Sciences Total Liabilities (Quarterly) : 568.90M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Natera, Inc. | 840.38M |
| Myriad Genetics, Inc. | 336.30M |
| BioRestorative Therapies, Inc. | 1.615M |
| CareDx, Inc. | 97.53M |
| Exagen, Inc. | 37.52M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.162B |
| Shareholders Equity (Quarterly) | 593.49M |
| Debt to Equity Ratio | 0.7261 |
| Current Ratio | 7.048 |
| Net Debt Paydown Yield | -0.03% |